Abstract
Hypophosphatemic rickets (HR) is a genetic disorder, which prevents sufficient reabsorption of phosphate in the proximal renal tubule, with increased phosphate excretion, resulting in rickets. The more common form of HR is an X-linked inherited trait, with a prevalence of 1/20,000. The defective gene is located on the X chromosome, but females may present with a wide variety of clinical manifestations. The less common form of HR is caused by autosomal-dominant transmission. Activating mutations of the fibroblast growth factor 23 (FGF-23) gene and inactivating mutations in the phosphate regulating gene (PHEX gene with homologies to endopeptidases on the X chromosome), involved in the regulation of FGF-23, have been identified and have been implicated in the pathogenesis of these disturbances. A review of etiopathogenesis and clinical, differential diagnostic and therapeutic aspects of HR, with a particular emphasis on bone impairment, is reported.
Similar content being viewed by others
References
Albright F, Butler AM, Bloomberg E (1937) Rickets resistant to vitamin D therapy. Am J Dis Child 54:529–547
Albright F, Reitenstein EC (1948) Parathyroid glands and metabolic bone disease. The Williams & Wilkins Co, Philadelphia
Arnstein AR, Frame B (1966) Primary hypophosphatemic rickets and osteomalacia: a review. Clin Orthop Relat Res 49:109–118
Barbour BH, KronWeld SJ, Pawlicki A (1964) On the mechanism of tubular reabsorption of phosphorous in vitamin D resistant rickets. Clin Res 12:247
de Beur SMJ, Levine MA (2002) Molecular pathogenesis of hypophosphatemic rickets. J Clin Endocrinol Metab 87:2467–2473
Wharton B, Bishop N (2003) Rickets. Lancet 362:1389–1400
Tenenhouse HS, Beck L (1966) Renal Na–P cotransporter gene expression in X-linked Hyp and Gy mice. Kidney Int 49:1027–1032
Cho HY, Lee BJ, Kang JH, Ha IS et al (2005) A clinical and molecular genetic study of hypophosphatemic rickets in children. Pediatr Res 58(2):329–333
Bielesz B, Klaushofer K, Oberbauer R (2004) Renal phosphate loss in hereditary and acquired disorders of bone mineralization. Bone 35:1229–1239
Bowe AE, Finnegan R, de Beur SMJ et al (2001) FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate. Biochem Biophys Res Commun 284:977–981
Beck L, Soumounou Y, Martel J et al (1997) Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 99:1200–1209
Levy-Litan V, Hershkowitz E, Avizov L et al (2010) Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet 86:273–278
Rutsch F, Ruf N, Vaingankar S et al (2003) Mutations in ENPP1 are associated with ‘idiopathic’ infantile arterial calcification. Nat Genet 34:379–381
Shimada T, Hasegawa H, Yamazaki Y et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435
Farrow EG, White KE (2010) Recent advances in renal phosphate handling. Nat Rev Nephrol 6:207–217
Hu MC, Shi M, Zhang J et al (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24:3438–3450
Quarles LD (2003) Evidence for a bone–kidney axis regulating phosphate homeostasis. J Clin Invest 112:642–646
Jonsson KB, Zahradnik R, Larsson T et al (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656–1663
de Menezes FH, de Castro LC, Damiani D (2006) Hypophosphatemic rickets and osteomalacia. Arq Bras Endocrinol Metabol 50(4):802–813
Gaasbeek A, Meinders AE (2005) Hypophosphatemia: an update on its etiology and treatment. Am J Med 118:1094–1101
Amanzadeh J, Reilly RF Jr (2006) Hypophosphatemia: an evidence-based approach to its clinical consequences and management. Nat Clin Pract Nephrol 2:136–148
Murer H, Forster I, Biber J (2004) The sodium phosphate cotransporter family SLC34. Pflugers Arch 447:763–767
Favus MJ (2002) Intestinal absorption of calcium, magnesium and phosphorus. In: Favus MJ, Coe FL (eds) Disorders of bone and mineral metabolism, 2nd edn. Lippincott Williams and Wilkins, New York, pp 48–73
Segawa H, Kaneko I, Yamanaka S et al (2004) Intestinal Na–P(i) cotransporter adaptation to dietary P(i) content in vitamin D receptor null mice. Am J Physiol Renal Physiol 287:F39–F47
Glorieux FH, Marie PJ, Pettifor JM et al (1980) Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med 303:1023–1031
Root AW, Diamond FB Jr (2002) Disorders of calcium metabolism in the child and adolescent. In: Saunders WB (ed) Pediatric endocrinology, vol 646, 2nd edn. Sperling, Philadelphia
Gordon C, DePeter K, Feldman H et al (2004) Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158:531–537
Pettifor JM (2003) Nutritional and drug-induced rickets and osteomalacia. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, vol 399, 5th edn. American Society for Bone and Mineral Research, Washington
Mughal Z (2002) Rickets in childhood. Semin Musculoskelet Radiol 6:183–190
Holm IA, Econs MJ, Carpenter TO (2003) Familial hypophosphatemia and related disorders. In: Juppner H, Pettifor JM, Glorieux FH (eds) Pediatric bone: biology and diseases. Academic Press, San Diego, pp 603–631
Petje G, Meizer R, Radler C et al (2008) Deformity correction in children with hereditary hypophosphatemic rickets. Clin Orthop Relat Res 466(12):3078–3085
Carpenter TO, Imel AE, Holm IA et al (2011) A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res 26(7):1381–1388
Sayer JA, Pearce SH (2001) Diagnosis and clinical biochemistry of inherited tubulopathies. Ann Clin Biochem 38:459–470
Tenenhouse HS, Econs MJ (2001) Mendelian hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease, 8th edn. McGraw Hill, New York, pp 5039–5067
Moncrieff MW (1982) Early biochemical findings in familial hypophosphatemic, hyperphosphaturic rickets and response to treatment. Arch Dis Child 57:70–72
Makitie O, Doria A, Kooh SW et al (2003) Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets. J Clin Endocrinol Metab 88:3591–3597
Verge CF, Lam A, Simpson JM et al (1991) Effects of therapy in X-linked hypophosphatemic rickets. N Engl J Med 325:1843–1848
Petersen DJ, Boniface AM, Schranck FW et al (1992) X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy. J Bone Miner Res 7:583–590
Makitie O, Kooh SW, Sochett E (2003) Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets. Clin Endocrinol 58:163–168
Harrell RM, Lyles KW, Harrelson JM et al (1985) Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. J Clin Invest 75:1858–1868
Carpenter TO (1997) New perspectives on the biology and treatment of X-linked hypophosphatemic rickets. Pediatr Clin North Am 44:443–466
Patel L, Clayton PE, Brain C et al (1996) Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphataemic rickets. Clin Endocrinol 44:687–696
Ariceta G, Langman CB (2007) Growth in X-linked hypophosphatemic rickets. Eur J Pediatr 166:303–309
Makitie O, Toiviainen-Salo S, Marttinen E et al (2008) Metabolic control and growth during exclusive growth hormone treatment in X-linked hypophosphatemic rickets. Horm Res 69:212–220
Haffner D, Wuhl E, Blum WF et al (1995) Disproportionate growth following long-term growth hormone treatment in short children with X-linked hypophosphataemia. Eur J Pediatr 154:610–613
Ferris B, Walker C, Jackson A et al (1991) Orthopaedic management of hypophosphatemic rickets. J Pediatr Orthop 11:367–373
Eyres KS, Brown J, Douglas DL (1993) Osteotomy and intramedullary nailing for the correction of progressive deformity in vitamin D-resistant hypophosphatemic rickets. J R Coll Surg Edinb 38:50–54
Novais E, Stevens PM (2006) Hypophosphatemic rickets: the role of hemiepiphysiodesis. J Pediatr Orthop 26:238–244
Rubinovitch M, Said SE, Glorieux FH et al (1988) Principles and results of corrective lower limb osteotomies for patients with vitamin D-resistant hypophosphatemic rickets. Clin Orthop Relat Res 237:264–270
Alon US, Monzavi R, Lilien M et al (2003) Hypertension in hypophosphatemic rickets—role of secondary hyperparathyroidism. Pediatr Nephrol 18:155–158
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pavone, V., Testa, G., Gioitta Iachino, S. et al. Hypophosphatemic rickets: etiology, clinical features and treatment. Eur J Orthop Surg Traumatol 25, 221–226 (2015). https://doi.org/10.1007/s00590-014-1496-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00590-014-1496-y